logo

MEDICAMEQ vs PGHL: Stock Comparison

MEDICAMEQ vs PROCTER & GAMBLE HEALTH LUpdated 17 Sept 26, 4:08 PM ISTNSE & company filings

PROCTER & GAMBLE HEALTH L is the larger company by market capitalisation. MEDICAMEQ shows faster revenue growth, while PROCTER & GAMBLE HEALTH L shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MEDICAMEQ leads 2; PGHL leads 9 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MEDICAMEQPGHL

Valuation lens

What price are you paying?

Market CapContext only
₹362 Cr
₹8,398 Cr
P/E RatioPGHL has the lower reading
36.16x
23.53x ✓
P/B RatioMEDICAMEQ has the lower reading
1.42x ✓
16.01x
EPSPGHL has the higher reading
₹1.56
₹57.92 ✓
Book ValueContext only
₹203.17
₹316.01
Dividend YieldPGHL has the higher reading
0.37%
2.77% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
PGHL is the larger company
₹8,398 Cr vs ₹362 Cr
P/E Ratio
PGHL has a lower P/E
23.53x vs 36.16x
P/B Ratio
MEDICAMEQ has a lower P/B
1.42x vs 16.01x
EPS
PGHL has higher earnings per share
₹57.92 vs ₹1.56
Dividend Yield
PGHL has a higher dividend yield
2.77% vs 0.37%
Revenue Growth (TTM YoY)
MEDICAMEQ has faster revenue growth
80.2% vs 19.1%
EPS Growth (TTM YoY)
PGHL has faster EPS growth
54.6% vs 44.7%
ROE
PGHL has a higher ROE
62.32% vs 3.36%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMEDICAMEQPGHL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMEDICAMEQPGHL
Live Price₹346.3₹5,062.5
Day Change0.23%0.29%
Volume1.29 L8,364
52-Week High₹447.65₹6,975
52-Week Low₹212.4₹4,707
Distance from 52W High-22.64%-27.42%

Valuation

MetricMEDICAMEQPGHL
Market Cap₹362 Cr₹8,398 Cr
P/E Ratio36.16x23.53x
P/B Ratio1.42x16.01x
EPS₹1.56₹57.92
Book Value₹203.17₹316.01
Dividend Yield0.37%2.77%

Growth

MetricMEDICAMEQPGHL
Revenue Growth (TTM YoY)80.2%19.1%
EPS Growth (TTM YoY)44.7%54.6%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricMEDICAMEQPGHL
ROE3.36%62.32%
ROCE4.09%92.1%
Net Margin5.21%23.22%
Operating Margin8.01%31.99%
Debt to Equity0.13x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricMEDICAMEQPGHL
Promoter Holding40.46%0%
FII Holding0.07%▼ 0.03 pp6.42%▲ 0.09 pp
DII Holding0.4%▲ 0.4 pp12.63%▲ 0.19 pp
Public Holding59.02%▼ 0.37 pp29.13%▼ 0.29 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MEDICAMEQ and PROCTER & GAMBLE HEALTH L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.